Search

everythinglearnresearchcommunity

for

Search:↓

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

5α-reductase affects dopamine receptors linked to sensorimotor gating, which may help understand disorders like schizophrenia.

The research gives new understanding on how human steroid 5α-reductases work and how drugs like finasteride inhibit them, which could help in creating new drugs.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

5-alpha-reductase inhibitors can effectively treat benign prostatic hyperplasia.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

Using hair loss drugs finasteride and dutasteride may cause sexual side effects.

New compounds may soon be tested to treat excessive hair growth in women.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Using 5-alpha reductase inhibitors may lower the risk of breast cancer in females.

5ARIs like finasteride can help prevent prostate cancer and treat BPH, but guidelines should be updated to reflect this.

Finasteride and dutasteride are effective for male hair loss and enlarged prostate but may cause reversible sexual side effects.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

5-Alpha reductase inhibitors are safe long-term but may be outdated for preventing less significant prostate cancer.

Taking 5-alpha reductase inhibitors does not increase breast cancer risk in men.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

Finasteride reduces certain behaviors caused by D1-like receptor agonists but not by D2-like receptor agonists in mice.

SRD5A1 is crucial in advanced prostate cancer, and blocking both SRD5A1 and SRD5A2 is more effective than targeting SRD5A2 alone.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.